Pfizer preps a laundry list of drug price hikes for the New Year — let the political fireworks begin
Pfizer is billing this as a restrained and completely reasonable move, but the pharma giant has just thrown down a gauntlet begging President Donald Trump to pick it up.
On Friday afternoon the pharma giant $PFE put out a statement saying that it’s holding the price line on 90% of its drug portfolio come the New Year. But 41 of its drugs have been picked for a price hike on January 15, averaging 5%. And one of those drugs, which Pfizer said has just been approved for 2 new indications after extensive R&D work, is in line for a 9% hike.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.